West China Hospital — Chengdu, Sichuan

Public research footprint of West China Hospital, compiled from the ClinicalTrials.gov public registry.

2,007

Registered studies

904

Active

517

Recruiting now

671

Completed

Stopped or withdrawn

Most-studied conditions

Advanced Non-Small Cell Lung Cancer · Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer · Moderately to Severely Active Ulcerative Colitis · Follicular Lymphoma (FL)

Recently updated registry entries

NCT06203210 — A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With… (Recruiting)
NCT06790693 — A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and… (Recruiting)
NCT04613596 — Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at West China Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.